BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21504390)

  • 1. Impact of current antiretroviral therapies on neuroAIDS.
    Vivithanaporn P; Gill MJ; Power C
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):371-4. PubMed ID: 21504390
    [No Abstract]   [Full Text] [Related]  

  • 2. NeuroAIDS in sub-Saharan Africa: a clinical review.
    Alkali NH; Bwala SA; Nyandaiti YW; Danesi MA
    Ann Afr Med; 2013; 12(1):1-10. PubMed ID: 23480988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
    Kishida S
    No To Shinkei; 2004 Apr; 56(4):301-10. PubMed ID: 15237721
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell death mechanisms in HIV-associated dementia: the involvement of syncytia.
    Nardacci R; Antinori A; Kroemer G; Piacentini M
    Cell Death Differ; 2005 Aug; 12 Suppl 1():855-8. PubMed ID: 15846379
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-associated dementia in the era of highly active antiretroviral therapy (HAART).
    Xia C; Luo D; Yu X; Jiang S; Liu S
    Microbes Infect; 2011 May; 13(5):419-25. PubMed ID: 21262373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?
    Vissers M; Stelma FF; Koopmans PP
    J Clin Virol; 2010 Dec; 49(4):231-8. PubMed ID: 20833583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy.
    Power C; Gill MJ; Johnson RT
    Can J Neurol Sci; 2002 Feb; 29(1):19-32. PubMed ID: 11858531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of opportunistic infections and lymphoma in the nervous system.
    Loy CT; Brew BJ
    J HIV Ther; 2002 Feb; 7(1):21-5. PubMed ID: 11956501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1.
    Taiwo B; Hicks C; Eron J
    J Antimicrob Chemother; 2010 Jun; 65(6):1100-7. PubMed ID: 20348088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era.
    Moroni M; Antinori S
    AIDS; 2003 Apr; 17 Suppl 1():S51-64. PubMed ID: 12870531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
    Arendt G
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):577-86. PubMed ID: 16217698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system.
    Nath A; Sacktor N
    Curr Opin Neurol; 2006 Aug; 19(4):358-61. PubMed ID: 16914973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NeuroAIDS: a neuroscience problem with global impact.
    Nunn MF
    Curr HIV Res; 2006 Jul; 4(3):245-7. PubMed ID: 16842077
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV in the brain: an interview with Dr. Michael Wool, UCLA researcher.
    Wool M
    Posit Dir News; 1998 Jan; 10(1):18-24. PubMed ID: 11365052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study.
    Lescure FX; Omland LH; Engsig FN; Roed C; Gerstoft J; Pialoux G; Kronborg G; Larsen CS; Obel N
    Clin Infect Dis; 2011 Jan; 52(2):235-43. PubMed ID: 21288850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAART & the molecular biology of AIDS dementia complex.
    Saksena NK; Smit TK
    Indian J Med Res; 2005 Apr; 121(4):256-69. PubMed ID: 15817943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic disease in injection drug users: therapeutic issues.
    Royal W
    J Neurovirol; 2000 May; 6 Suppl 1():S33-7. PubMed ID: 10871763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS.
    Kumar S; Maurya VK; Dandu HR; Bhatt ML; Saxena SK
    Biomol Concepts; 2018 May; 9(1):33-42. PubMed ID: 29742062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update on the neurological consequences of HIV-1 infection (2006)].
    Tardieu M
    Rev Neurol (Paris); 2006 Jan; 162(1):19-21. PubMed ID: 16446620
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system.
    Price RW
    Res Publ Assoc Res Nerv Ment Dis; 1994; 72():1-45. PubMed ID: 8115708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.